EAM
MDCXW

Empery Asset Management’s Medicus Pharma Warrant MDCXW Stock Holding History

Empery Asset Management’s Portfolio MDCXW Stock Details MDCXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,100
Closed -$11.5K – 41
2026
Q1 		$11.5K Hold
12,100
– – 0.01% 29
2025
Q4 		$9.68K Buy
+12,100
New +$11.3K 0.01% 29

Other funds holding MDCXW

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Empery Asset Management's MDCXW Position: Q2 2026 in Review

Empery Asset Management sold out of Medicus Pharma Warrant (MDCXW) in Q2 2026, closing a stake of 12,100 shares — an estimated $11.5K sold.

Empery Asset Management first reported a position in MDCXW in Q4 2025 and held it in 2 quarters. The position peaked at $11.5K in Q1 2026. 4 funds tracked by Wall St. Rank hold MDCXW as of Q2 2026.

  • Empery Asset Management reported no remaining Medicus Pharma Warrant position as of Q2 2026 after selling out during the quarter.
  • Empery Asset Management sold 12,100 Medicus Pharma Warrant shares in Q2 2026, an estimated $11.5K.
  • Empery Asset Management first reported a position in Medicus Pharma Warrant in Q4 2025 and held it in 2 quarters.
  • Empery Asset Management's Medicus Pharma Warrant position peaked at $11.5K in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q2 2026.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.